Skip to main content

Table 1 Demographic data of the study population

From: Role of urinary NAG enzyme in early detection of renal impairment in cystic fibrosis patients

Variables N=40 (100%) Median (Max–Min)
Age in years   6 (12–2.5)
Age of presentation in months   5 (72–1.0)
Duration of disease in months   56 (12–108)
Duration of use of nephrotoxic drugs in months   28 (6–54)
Residence
 Urban 19 (47.5%)  
 Rural 21 (52.5%)  
Sex
 Male 24 (60%)  
 Female 16(40%)  
Positive consanguinity 18 (45%)  
Positive family history with CF 10 (25%)